Extracellular Vesicle-based Dx & Rx Summit

Date: Thursday, 28 March 2019
Location: Coronado Island, California

Conference Chair

Lucia R. Languino
Professor of Cancer Biology, Thomas Jefferson University

Keynote Speakers

Hollis Cline
Chair of Neuroscience and Hahn Professor of Neuroscience, The Scripps Research Institute

Jan Lötvall
Professor, University of Gothenburg; Founding President of ISEV; Editor-in-Chief, Journal of Extracellular Vesicles

Chulhee Choi
Professor and Chair, BioMedical Imaging Center, Korea Advanced Institute of Science and Technology (KAIST), President, ILIAS Biologics Incorporated

Dominique PV de Kleijn
Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands

Overview

SelectBIO Extracellular Vesicles (EVs)-based Diagnostics and Therapeutics Summit 2019 focuses on the emerging field of deploying Exosomes as diagnostics and the engineering of exosomes and extracellular vesicles as a delivery tool for therapeutics moieties.

The ability to engineer EVs and the ability of EVs to target specific sites offers the ability to tailor therapeutics with exquisite targeting ability and opens up a whole new class of therapeutics which are classified as biologicals and which do not have the side effects and toxicity associated with small molecule-based therapies.

This summit explores this topic and takes a deep dive into the technology platforms, diseases targeted and clinical results-to-date.

This summit is co-located and concurrent with the Circulating Biomarkers World Congress 2019 and Liquid Biopsies 2019 events providing a 360^o view of the field of exosomes and other circulating biomarker classes from biomarker/diagnostic potential to therapeutics opportunities in the future.

Information and Local Registration Facilities for this Conference are also available in:

Japanese | Korean | Chinese (Simplified) | Chinese (Traditional)

Agenda Topics

Engineering EVs as Biologic Drugs
Engineering Exosomes and Extracellular Vesicles (EVs)
Ex Vivo Production of Large Quantities of EVs: Challenges and Opportunities
Exosomes-based Diagnostics Development

Diagnostics Markers Carried by Exosomes
Liquid Biopsy Enabled by Analyzing Exosomes

Stem Cell-based EVs for Regenerative Medicine

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Confirmed Speakers to date

Randolph Corteling, Head of Research, ReNeuron Ltd.
Clayton Deighan, North American Sales and Applications Manager, NanoFCM
Daniel Gau, Head of Business Development, Unicyte AG
Michael Graner, Professor, Dept of Neurosurgery, University of Colorado Anschutz School of Medicine
Dana Larocca, VP Discovery Research, AgeX Therapeutics
Aurelio Lorico, Professor of Pathology, Touro University Nevada School of Medicine
John Ludlow, Executive Director, Regenerative Medicine, Zen-Bio, Inc.
Shannon Pendergrast, Chief Scientific Officer, Ymir Genomics
Davide Trotti, Professor, Scientific Director, Weinberg ALS Center, Vickie and Jack Farber Institute for Neuroscience, Thomas Jefferson University

Corporate Sponsors	Media Sponsors	Official Journal Partner	Networking

Add to Calendar ▼2019-03-28 00:00:002019-03-28 00:00:00Europe/LondonExtracellular Vesicle-based Dx and Rx SummitExtracellular Vesicle-based Dx and Rx Summit in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors